CPU 7810 Inpatient Detoxification Service

Location

Nottinghamshire

Description

The Provider will be required to deliver a dedicated Drug and Alcohol Inpatient Detoxification Service which is to be located within the boundary of Nottinghamshire for eligible adults resident within Nottingham City

Total Quantity or Scope

The Provider will be required to deliver a dedicated Drug and Alcohol Inpatient Detoxification Service which is to be located within the boundary of Nottinghamshire for eligible adults resident within Nottingham City. Nottingham City Council intends to award a Contract under Direct Award C of the Provider Selection Regime 2023. The lifetime of the contract value is £2,100,313 excluding VAT. The anticipated contract start date is 1 July 2026 until 30 September 2028. There are two options to extend on a 2 + 2 basis.

Award Detail

Renewal Options

The Contract contains two options to extend at the Councils discretion on a 2 + 2 basis until 30 September 2032

Award Criteria

CPV Codes

• 85312500 - Rehabilitation services

Indicators

• Options are available.
• Award on basis of price.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on 21st May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by midnight 21 May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Any representation must be made to phcontracting@nottinghamcity.gov.uk Conflicts of Interest identified: there were no Conflicts of Interest in the Panel or award decision makers. The Provider was evaluated through a formal written submission evidencing how they would meet the Key Criteria. A minimum overall score of 50% was required to proceed with the award. The Provider achieved an overall score of 78.5% and therefore met the required threshold. The Key Criteria were weighed as follows: • Quality and Innovation - 35% • Value - 15% • Integration, Collaboration and Service Sustainability - 25% • Improving Access, Reducing Health Inequalities and Facilitating Choice - 10% • Social Value - 15% The key criteria were determined in line with the Provider Selection Regime (PSR) guidance and informed by local public health expertise and knowledge of the service. Greater weighting was given to criteria reflecting the high-risk nature of inpatient detoxification as a specialist medical intervention, including clinical safety, quality, and alignment with national substance use and clinical guidance. Additional importance was placed on the provider's ability to integrate effectively within the wider Nottingham City substance use treatment pathway and to respond to local needs and priorities. Consideration was also given to securing best value for money, ensuring that the service delivers optimal outcomes in a cost-effective manner. The relative importance of these criteria reflects the need to balance patient safety, service quality, system integration, and value in commissioning this critical service. The Decision maker is the Director of Public Health at Nottingham City Council under delegated authority awarded at Commissioning and Procurement Executive Committee on 10 February 2026